SEO URLwww.firestrike.ai/deals/cspc-pharmaceutical-group-astrazeneca-acquisition-2026-2
acquisitionAnnounced · Feb 1, 2026PharmaceuticalsSource · Community DiscussionsArticle · Factual
AstraZeneca acquires CSPC Pharmaceutical Group
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$5B
Target
CSPC Pharmaceutical Group
Acquirer
AstraZeneca
Financial Stake
Status
Announced
AstraZeneca agreed to acquire CSPC Pharmaceutical Group. Reported deal value: $5B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-02-01. Figures and status may change as filings and press coverage update.
AstraZeneca , the British-Swedish pharma giant, has concluded a major licensing agreement with China CSPC Pharmaceutical Group worth up to 18 .5 billion dollars
Deal timeline
Announced
Feb 1, 2026 · ca.marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $5B. Figures and status may change as sources update.
Sources: ca.marketscreener.com · Primary article · FireStrike proprietary index